영어뉴스 공부하기: Sanofi forecasts profit growth amid competition

* 예상 : expect / forecast => 수치예상 estimate, projection

---

# Sanofi on Friday forecast moderate earnings growth this year. It said higher demand for bestselling asthma and eczema drug Dupixent would be offset by increasing competition for its multiple sclerosis pill Aubagio. 
It said the tablet, with over $2 billion in sales last year, will face rival cheaper products after losing patent protection.

 

* modest 소폭

* moderate 중간/ 평균 => 무난한 / 준수한 = decent 

* higher demand 수요증가

* eczema 습진

a medical condition that makes your skin dry, sore, and itchy

 

* asthma 천식

a medical condition that makes it difficult to breathe

 

* multiple sclerosis 다발성 경화증

a process in which a soft organ or soft tissue in your body becomes hard

 

* go generic 

* generic drugs 카피약

---

# The French drugmaker said it expected 2023 earnings per share to grow by a “low single digit” percentage. Sanofi’s fourth quarter operating income jumped over 20% to around $3 billion, edging past analyst estimates.
The company reaffirmed its Dupixent sales target of around $11 billion this year, up more than a fifth from 2022. The drugmaker is also seeking to widen the pill’s use across more conditions, with investors waiting on trials with smokers and lung disease sufferers.

Sanofi shares fell 3% in early Friday trade, following the firm's cautious outlook.

 

* EPS 주당 순이익 / Earnings per share

* a low single digit 한자리수인데 낮음

* edge (절벽으로 조금씩 조금씩 소폭으로 이동) * inch tick 소폭 움직이다. 간신히, 소폭 

* trial(s) 임상실험

* early trade 장초반

* following = after